Another study regarding Fludarabine resistant CLL cells found that HIF-1α was overexpressed, specifically in TP53- disrupted cells. Thus, its inhibition, using BAY87-2243, exerted a potent anti-tumor function within these cells overcoming Fludarabine resistance [27]. This evidence concerns the gene HIF1A and B-cell chronic lymphocytic leukemia.